Soligenix, Inc. Made Headway

Wed, May 27, 2026 at 07:53 PM

Soligenix, Inc. (SNGX:NASDAQ) shot up at $0.87, representing a gain of 68.8%. On Wed, May 27, 2026, SNGX:NASDAQ touched a New 2-Week High of $0.87. The stock got featured on our News Catalysts scanner on Wed, May 27, 2026 at 10:28 AM in the 'BIOTECH' category. From Wed, May 13, 2026, the stock recorded 55.56% Up Days and 60.00% Green Days

The stock spiked on Wed, May 27, 2026 at $1.13 with a volume of 239M+.

About Soligenix, Inc. (SNGX:NASDAQ)

Soligenix Inc is a clinical stage biopharmaceutical company focused on focused on developing and commercializing products to treat rare diseases where there is an unmet medical need.

Top 10 Gainers:

Astrotech Corporation (ASTC:NASDAQ), 459.11%
NetClass Technology Inc (NTCL:NASDAQ), 110.15%
Hoth Therapeutics, Inc. (HOTH:NASDAQ), 92.01%
Q32 Bio Inc. (QTTB:NASDAQ), 81.24%
AIM ImmunoTech Inc. (AIM:NYSEMKT), 72.37%
Soligenix, Inc. (SNGX:NASDAQ), 68.75%
VCI Global Limited (VCIG:NASDAQ), 64.83%
AMASS Brands Inc. (AMSS:NASDAQ), 59.22%
Smart for Life, Inc. (SMFL:NASDAQ), 50%
Virtuix Holdings Inc. (VTIX:NASDAQ), 46.33%